Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
ACE2
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
ACE2
Emergency use authorization Experimental Antiviral Jan/23/2023
Mesenchymal stem cells
ACE2
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
Sotrovimab
ACE2
Emergency use authorization Experimental Antiviral Jul/14/2022
Etesevimab
ACE2
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
S309
ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022
BNT162b2
ACE2
Approved by FDA Experimental Vaccine Jun/22/2022
Cilgavimab
ACE2
Emergency use authorization Experimental Antiviral Jun/18/2022
Tixagevimab
ACE2
Emergency use authorization Experimental Antiviral Jun/18/2022
REGEN-COV
ACE2
Emergency use authorization Experimental Antiviral Jun/03/2022
Convalescent plasma
ACE2
Emergency use authorization Experimental Antiviral May/16/2022
ACE2‐Fc
ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/26/2022
Ivermectin
ACE2
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
P2C-1F11
ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022
hu33
ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022
PDA@Exosome
ACE2
Potential treatment - pre-clinical evidence Experimental Other treatment Jan/22/2022
Dexamethasone
ACE2
Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
S2K146
ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/06/2022
mAb 222
ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-55
ACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022